Shuttle Pharmaceuticals Holdings, Inc. (SHPH)Healthcare | Drug Manufacturers - Specialty & Generic | Gaithersburg, United States | NasdaqCM
1.02 USD
-0.01
(-0.971%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.97 -0.05 (-0.050%) ⇩ (April 17, 2026, 7:58 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 19, 2026, 12:54 a.m. EDT
Despite recent equity raises and AI buzz, Shuttle Pharmaceuticals (SHPH) exhibits severe financial distress with a 58% drop below its 200-day average, 15-year track record as a deep value trap, and a short-term model predicting a -20% correction, outweighing speculation on AI partnerships. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.520032 |
| MSTL | 0.621938 |
| AutoETS | 0.673300 |
| AutoARIMA | 0.673330 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 46% |
| H-stat | 6.18 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.173 |
| Excess Kurtosis | -0.27 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 10.297 |
| Market Cap | 5,703,115 |
| Beta | 0.72 |
| Website | https://www.shuttlepharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8374502 |
| Address1 | 401 Professional Drive |
| Address2 | Suite 260 |
| All Time High | 25,252.0 |
| All Time Low | 0.5 |
| Ask | 1.04 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 195,950 |
| Average Daily Volume3 Month | 371,231 |
| Average Volume | 371,231 |
| Average Volume10Days | 195,950 |
| Beta | 0.723 |
| Bid | 0.9745 |
| Bid Size | 1 |
| Book Value | 1.128 |
| City | Gaithersburg |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.02 |
| Current Ratio | 0.063 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.02 |
| Day Low | 0.96 |
| Debt To Equity | 10.297 |
| Display Name | Shuttle Pharmaceuticals |
| Ebitda | -11,626,717 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.482 |
| Enterprise Value | 5,601,258 |
| Eps Trailing Twelve Months | -7.16 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.968 |
| Fifty Day Average Change | 0.051999986 |
| Fifty Day Average Change Percent | 0.053718995 |
| Fifty Two Week Change Percent | -83.74502 |
| Fifty Two Week High | 11.25 |
| Fifty Two Week High Change | -10.23 |
| Fifty Two Week High Change Percent | -0.9093333 |
| Fifty Two Week Low | 0.5 |
| Fifty Two Week Low Change | 0.52 |
| Fifty Two Week Low Change Percent | 1.04 |
| Fifty Two Week Range | 0.5 - 11.25 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,661,952,600,000 |
| Float Shares | 5,563,837 |
| Free Cashflow | 1,194,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 2 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0094 |
| Held Percent Institutions | 0.03091 |
| Implied Shares Outstanding | 5,591,290 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,750,032,000 |
| Last Split Factor | 1:25 |
| Long Business Summary | Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland. |
| Long Name | Shuttle Pharmaceuticals Holdings, Inc. |
| Market | us_market |
| Market Cap | 5,703,115 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_319499082 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -11,721,669 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 5,647,202 |
| Open | 1.0103 |
| Operating Cashflow | -9,481,645 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 240 403 4212 |
| Post Market Change | -0.050499976 |
| Post Market Change Percent | -4.950978 |
| Post Market Price | 0.9695 |
| Post Market Time | 1,776,470,325 |
| Previous Close | 1.03 |
| Price Hint | 4 |
| Price To Book | 0.9042553 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.042 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00999999 |
| Regular Market Change Percent | -0.970873 |
| Regular Market Day High | 1.02 |
| Regular Market Day Low | 0.96 |
| Regular Market Day Range | 0.96 - 1.02 |
| Regular Market Open | 1.0103 |
| Regular Market Previous Close | 1.03 |
| Regular Market Price | 1.02 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 72,296 |
| Return On Assets | -1.1474099 |
| Return On Equity | -7.9104304 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 5,591,290 |
| Shares Percent Shares Out | 0.0207 |
| Shares Short | 115,865 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 45,206 |
| Short Name | Shuttle Pharmaceuticals Holding |
| Short Percent Of Float | 0.0208 |
| Short Ratio | 0.52 |
| Source Interval | 15 |
| State | MD |
| Symbol | SHPH |
| Total Cash | 334,005 |
| Total Cash Per Share | 0.06 |
| Total Debt | 232,147 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -7.16 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.455955 |
| Two Hundred Day Average Change | -1.435955 |
| Two Hundred Day Average Change Percent | -0.58468294 |
| Type Disp | Equity |
| Volume | 72,296 |
| Website | https://www.shuttlepharma.com |
| Zip | 20,879 |